PSIVIDA CORP. (PVA)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: pSivida Corp
Stock Code: PVA
Website: www.psivida.com
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 25
Equiv. Shares (M): 9

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 2.850 $ 0.000 $ 0.000 $ 0.000 $ 2.850 0 0%

Company Overview

Business Description:
pSivida Corp (PVA) is involved in the development of miniaturised, injectable, drug delivery systems. PVA’s intellectual property portfolio consists of over 150 issued patents in countries including the U.S., Europe, Japan, China and Australia. The developed products include Durasert, Iluvien, Retisert, Vitrasert and Tethadur.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -24.4 -117.2 -- 0.0 0.0 0.0 --
2011  A -8.0 -41.2 -176.3 0.0 0.0 0.0 --
2010  A 10.3 54.0 -- 7.2 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Acrux Limited (ACR) $638 M -0.8713 0.9775 0.7380 86.2613 43.6219 25.0983 0.0209 0.0197 0.0456
pSivida (PVA) $26 M -- -- -- -- -- -- 0.0000 -- --
Pharmaxis (PXS) $42 M -- -- -- -- -- -- 0.0000 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
PVA -- -- 4.43 -- 41.8
Market 1.08 13.3 0.91 2.59 2.57
Sector 0.93 21.0 2.33 0.55 6.87

Directors
Name Position Start Date
Dr David J Mazzo Chairman 25 July 2005
Dr Paul Ashton Managing Director,Chief Executive Officer,President 30 December 2005
Mr Paul Hopper Non-Executive Director 09 July 2008
Mr Michael W Rogers Non-Executive Director 27 July 2005
Mr Douglas Godshall Non-Executive Director 05 March 2012
Peter G Savas Non-Executive Director 14 July 2008

Management
Name Position
Lori Freedman Company Secretary
Leonard S. Ross Vice President, Finance (Principal Financial and Accounting Officer)

Substantial Shareholders
Holding Name
-- (--%) Not Disclosed in Annual Report

Calendar of Events
Date Event
13 February 2014 Report (Interim)
27 September 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Shares via SMSFs

An educational booklet that outlines how to get the most from your share investments for retirement thorugh your self managed super fund.

More details...

News

Killing a golden goose

The Age 22/05/2013 | A piece of broker research came out last week that described the budget as a sensible one but an almost suicidal one for a government four months out from an election. Instead of trying to buy votes, it seemed intent instead on putting as many noses out of joint as it possibly could.

Tinkering undermines the system

The Age 22/05/2013 | In last week's budget, the government missed what will probably be its last opportunity to make the superannuation system fairer and more sustainable. While the government made some tough decisions, such as reneging on promised tax cuts, one of the fastest-growing expenses is the tax concessions for superannuation.

Exposure appeals as recession looms

The Age 22/05/2013 | What chance recession?

The cuts are now personal Grinding out the numbers

The Age 22/05/2013 | Baby, forget the bonus. With tax concessions gone the federal government's budget could also affect your health, writes John Collett.

The mother of all super shortfalls

The Age 22/05/2013 | Last week's budget was a bit of aho-hum affair on many levels related to superannuation, because most of the changes to the system had been announced back in April. The transfer of the Baby Bonus into an extra (reduced) payment for families eligible for Family Tax Benefit Part A, has drawn the light fairly and squarely on the costs of bearing and raising children. The recent debate about the opposition's Paid Parental Scheme versus the government's less-generous scheme has added fuel to the fire.

Tradies call for rescue after builder collapse

The Age 22/05/2013 | Tradies caught out by the collapse of National Buildplan Group have called for a financial "rescue" package and an investigation into the failure of the company.

More...


Sponsored Links

Feedback Form